Abnova Taiwan Corp

4133 • TW

NT$20.85-NT$0.05 (0.24%)

Estimate

P/E

521.3

EPS

0.04

Beta

0.293

Growth

Revenue, YoY

-2.86%

Net income, YoY

22.5%

FCF, YoY

425.53%

About the company

Ticker

4133

ISIN

TW0004133004

Country

Taiwan

Sector (GICS)

Healthcare

Abnova (Taiwan) Corporation engages in the research, development, manufacturing, and sales of monoclonal and multiclonal antibodies, proteins, medical diagnostic instruments, and testing reagents. The company's products portfolio includes SARS-CoV/CoV-2, DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, Nano, DNAxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company provides integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production and scale up; assay development services; circulating tumor cell and DNA; germline genetic DNA; and FFPE tumor tissue DNA services. It serves academic, research institutions, and pharmaceutical factories. Abnova (Taiwan) Corporation was founded in 2002 and is headquartered in Taipei, Taiwan.

Frequently asked questions

What sector does Abnova Taiwan Corp (4133) operate in?

Abnova Taiwan Corp belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Abnova Taiwan Corp (4133) current stock price?

As of the latest data, Abnova Taiwan Corp stock price is NT$20.85, with a previous close of NT$20.90. Abnova Taiwan Corp lost -NT$0.05 in the last trading session, representing a -0.24% loss.

What is Abnova Taiwan Corp (4133) current market capitalization?

Abnova Taiwan Corp market cap is approximately 1.26 billion.

What is Abnova Taiwan Corp (4133) Earnings Per Share (EPS)?

The trailing EPS is NT$0.04.

What is Abnova Taiwan Corp (4133) Price-to-Earnings (P/E) ratio?

Abnova Taiwan Corp current P/E ratio is 521.25.

What is Abnova Taiwan Corp (4133) EBITDA?

Abnova Taiwan Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 17.07 million.

Does Abnova Taiwan Corp (4133) pay dividends?

No. Abnova Taiwan Corp does not pay a dividend.

What is Abnova Taiwan Corp (4133) beta (volatility) score?

Abnova Taiwan Corp has a beta of 0.293, indicating lower volatility than the overall market.